|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019196,
umls-concept:C0021747,
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0205466,
umls-concept:C0229671,
umls-concept:C0332293,
umls-concept:C0681842,
umls-concept:C0751973,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2006-6-9
|
|
pubmed:abstractText |
Surface-enhanced laser desorption ionization time-of-flight mass spectrometry is a proteomic technique that enables the global profiling of proteins. We used this approach to monitor the kinetics of serum proteome in patients with chronic hepatitis C virus infection receiving a standard bitherapy regimen to predict treatment response.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
130
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2189-97
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16762639-Adult,
pubmed-meshheading:16762639-Aged,
pubmed-meshheading:16762639-Antiviral Agents,
pubmed-meshheading:16762639-Dose-Response Relationship, Drug,
pubmed-meshheading:16762639-Drug Administration Schedule,
pubmed-meshheading:16762639-Drug Therapy, Combination,
pubmed-meshheading:16762639-Female,
pubmed-meshheading:16762639-Follow-Up Studies,
pubmed-meshheading:16762639-Genetic Markers,
pubmed-meshheading:16762639-Hepatitis C, Chronic,
pubmed-meshheading:16762639-Humans,
pubmed-meshheading:16762639-Interferon-alpha,
pubmed-meshheading:16762639-Male,
pubmed-meshheading:16762639-Middle Aged,
pubmed-meshheading:16762639-Predictive Value of Tests,
pubmed-meshheading:16762639-Proteome,
pubmed-meshheading:16762639-Recombinant Proteins,
pubmed-meshheading:16762639-Retrospective Studies,
pubmed-meshheading:16762639-Ribavirin,
pubmed-meshheading:16762639-Risk Assessment,
pubmed-meshheading:16762639-Severity of Illness Index,
pubmed-meshheading:16762639-Treatment Outcome,
pubmed-meshheading:16762639-Viral Load
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin.
|
|
pubmed:affiliation |
Service d'Anatomie Pathologie, Hôpital Beaujon, and CNRS UMR 8149, Clichy, France. vparadis@teaser.fr
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
